“Medicare approval in the US is a huge step forward for the - TopicsExpress



          

“Medicare approval in the US is a huge step forward for the SomnoDent Herbst Advance devices and for sleep apnea treatment in general,” said Dr. Peter Neustadt, Chairman and CEO of SomnoMed. “Not only does the approval further strengthen SomnoMed’s global leadership position in COAT™ (Continuous Open Airway Therapy) treatment for obstructive sleep apnea, it enables a larger patient population access to the quality of life benefits that come with COAT treatment.”
Posted on: Fri, 26 Sep 2014 15:15:24 +0000

Recently Viewed Topics




© 2015